
Glenmark Pharmaceuticals Limited (GLENMARK)
NSEINR 1860.11.62%
Price Chart
Key Statistics
Market Cap
INR 524.92B
P/E Ratio
50.25
Revenue (TTM)
INR 134.35B
Volume
1.1M
52W High
INR 1879.40
52W Low
INR 1275.50
Dividend Yield
0.14%
Beta
0.20
Technicals
50-Day MA
1546.322
200-Day MA
1525.2598
52 Week High
1879.4
52 Week Low
1275.5
About GLENMARK
Glenmark Pharmaceuticals Limited, together with its subsidiaries, develops, manufactures, and sells generics, specialty products, and OTC pharmaceutical products in India, North America, Latin America.
Employees
N/A
Headquarters
Mumbai, India
CEO
Mr. Glenn Mario Saldanha
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg